Global Vitamin C Market- Industry Analysis, Share, Size, Growth, Trends, Opportunity and Forecast 2022-2030

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSIS
4.12 GE MATRIX
5 VITAMIN C TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 SODIUM ASCORBATE
5.6 CALCIUM ASCORBATE
5.7 POTASSIUM ASCORBATE
5.8 MAGNESIUM ASCORBATE
5.9 ASCORBIC ACID 90% GRANULATION
5.10 D-ISOASCORBIC ACID
5.11 ASCORBIC ACID 95% GRANULATION
5.12 ASCORBIC ACID 97% GRANULATION
5.13 COATED VITAMIN C
5.14 OTHERS
6 VITAMIN C SOURCE ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET SOURCE ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 NATURAL
6.6 SYNTHETIC
7 VITAMIN C FORM ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET FORM ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 TONIC
7.6 TABLET
7.7 GRANULES
7.8 INJECTION
8 VITAMIN C MARKET APPLICATION ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 PHARMACEUTICAL
8.6 COSMETICS
8.7 FOOD AND BEVERAGE
8.8 ANIMAL FEED
9 GLOBAL VITAMIN C REGIONAL ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
9.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.2.3 Y-O-Y GROWTH TREND ANALYSIS
9.2.3.1 U.S.
9.2.3.2 Canada
9.2.3.3 Mexico
9.3 ASIA-PACIFIC
9.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
9.3.2 Y-O-Y GROWTH TREND ANALYSIS
9.3.2.1 China
9.3.2.2 Japan
9.3.2.3 Korea
9.3.2.4 India
9.3.2.5 Southeast Asia
9.4 MIDDLE EAST AND AFRICA
9.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
9.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4.3 Y-O-Y GROWTH TREND ANALYSIS
9.4.3.1 Saudi Arabia
9.4.3.2 UAE
9.4.3.3 Egypt
9.4.3.4 Nigeria
9.4.3.5 South Africa
9.5 EUROPE
9.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
9.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.5.3 Y-O-Y GROWTH TREND ANALYSIS
9.5.3.1 Germany
9.5.3.2 France
9.5.3.3 UK
9.5.3.4 Russia
9.5.3.5 Italy
9.6 LATIN AMERICA
9.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
9.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.6.3 Y-O-Y GROWTH TREND ANALYSIS
9.6.3.1 Brazil
9.6.3.2 Argentina
9.6.3.3 Columbia
10 MARKET PLAYERS
10.1 FOODCHEM INTERNATIONAL CORPORATION
10.1.1 BUSINESS OVERVIEW:
10.1.2 PRODUCT PORTFOLIO
10.1.3 RECENT DEVELOPMENTS
10.1.4 SWOT ANALYSIS:
10.2 MUDANJIANG HIGH-TECH BIOCHEMICAL CO. LTD.
10.3 AMWAY INDIA ENTERPRISES PVT. LTD
10.4 CSPC PHARMACEUTICAL GROUP LIMITED
10.5 GLANBIA PLC
10.6 NORTHEAST PHARMACEUTICAL GROUP CO.,LTD.
10.7 THE TNN DEVELOPMENT LIMITED
10.8 MICROBELCAPS
10.9 BEIJING HERONSBILL FOOD MATERIAL CO.,LTD
10.10 DUCHEFA BIOCHEMIE
10.11 MEDIBRO CORPORATION LIMITED
10.12 CHEMIZO ENTERPRISE
10.13 DSM
10.14 DUPONT
10.15 ADM
10.16 SANOFI
10.17 BAYER AG
10.18 ABBOTT
10.19 GLAXOSMITHKLINE PLC
10.20 MERCK & CO., INC.
11 ABOUT US

FIGURE 1 GLOBAL VITAMIN C MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL VITAMIN C CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL VITAMIN C CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 VITAMIN C TYPE ANALYSIS
FIGURE 11 GLOBAL VITAMIN C CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 VITAMIN C SOURCE ANALYSIS
FIGURE 13 GLOBAL VITAMIN C CURRENT AND FUTURE MARKET SOURCE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 VITAMIN C FORM ANALYSIS
FIGURE 15 GLOBAL VITAMIN C CURRENT AND FUTURE MARKET FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 VITAMIN C APPLICATION ANALYSIS
FIGURE 17 GLOBAL VITAMIN C CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 GLOBAL VITAMIN C CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 19 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 MARKET SHARE BY COUNTRY
FIGURE 21 NORTH AMERICA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 NORTH AMERICA VITAMIN C CURRENT AND FUTURE SOURCE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 23 NORTH AMERICA VITAMIN C CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 U.S. VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 U.S. VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 CANADA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 CANADA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 MEXICO VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 MEXICO VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 MARKET SHARE BY COUNTRY
FIGURE 32 APAC VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 APAC VITAMIN C CURRENT AND FUTURE SOURCE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 APAC VITAMIN C CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 35 APAC VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 CHINA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 CHINA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 JAPAN VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 JAPAN VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 KOREA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 KOREA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 INDIA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 INDIA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 SOUTHEAST ASIA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 SOUTHEAST ASIA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 MARKET SHARE BY COUNTRY
FIGURE 47 MIDDLE EAST AND AFRICA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 MIDDLE EAST AND AFRICA VITAMIN C CURRENT AND FUTURE SOURCE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 MIDDLE EAST AND AFRICA VITAMIN C CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MIDDLE EAST AND AFRICA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 51 SAUDI ARABIA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 SAUDI ARABIA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 UAE VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 UAE VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 EGYPT VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 EGYPT VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 NIGERIA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 NIGERIA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 SOUTH AFRICA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 SOUTH AFRICA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 MARKET SHARE BY COUNTRY
FIGURE 62 EUROPE VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 EUROPE VITAMIN C CURRENT AND FUTURE SOURCE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 EUROPE VITAMIN C CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 EUROPE VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 GERMANY VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 67 GERMANY VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 FRANCE VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 FRANCE VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 UK VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 UK VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 RUSSIA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 RUSSIA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 ITALY VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 ITALY VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 MARKET SHARE BY COUNTRY
FIGURE 77 LATIN AMERICA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 LATIN AMERICA VITAMIN C CURRENT AND FUTURE SOURCE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 LATIN AMERICA VITAMIN C CURRENT AND FUTURE FORM ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 LATIN AMERICA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 BRAZIL VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 BRAZIL VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 83 ARGENTINA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 ARGENTINA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 COLUMBIA VITAMIN C CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 COLUMBIA VITAMIN C CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 FINANCIAL OVERVIEW: